Tianda Pharmaceuticals Ltd. (HK:0455) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tianda Pharmaceuticals has entered into a new framework agreement with TCH (China) Group, revising the expiry date of their existing agreement to align with their financial year-end and extending their collaboration until 2027. This renewal involves the continued purchase of packaging products and design services, highlighting a strategic move to streamline operations and enhance market agility. With these transactions, Tianda aims to solidify its market position while complying with regulatory requirements.
For further insights into HK:0455 stock, check out TipRanks’ Stock Analysis page.